Published in J Biol Chem on October 24, 1997
Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol (2012) 2.48
The TET family of proteins: functions and roles in disease. J Mol Cell Biol (2009) 1.97
CoAA, a nuclear receptor coactivator protein at the interface of transcriptional coactivation and RNA splicing. Mol Cell Biol (2004) 1.77
Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development. J Clin Invest (2007) 1.39
Human 100-kDa homologous DNA-pairing protein is the splicing factor PSF and promotes DNA strand invasion. Nucleic Acids Res (2000) 1.12
Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family. Sarcoma (2010) 1.11
Downstream EWS/FLI1 - upstream Ewing's sarcoma. Genome Med (2010) 1.01
O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma. Oncogene (2009) 0.95
Ewing sarcoma protein: a key player in human cancer. Int J Cell Biol (2013) 0.94
Phosphorylation by SR kinases regulates the binding of PTB-associated splicing factor (PSF) to the pre-mRNA polypyrimidine tract. FEBS Lett (2006) 0.89
Modification of EWS/WT1 functional properties by phosphorylation. Proc Natl Acad Sci U S A (1999) 0.89
RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains. Nucleic Acids Res (2005) 0.84
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma. Blood (2007) 0.83
Identification of a self-association domain in the Ewing's sarcoma protein: a novel function for arginine-glycine-glycine rich motifs? J Biochem (2010) 0.80
Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells. J Biol Chem (2016) 0.78
Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma. Sarcoma (2011) 0.78
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model. Oncotarget (2015) 0.78
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature (1998) 7.55
Polymyxin and related peptide antibiotics. Annu Rev Biochem (1977) 4.53
Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci (1998) 3.33
Ca2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature (1999) 3.24
Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron (1998) 3.08
Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci U S A (1993) 3.07
Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron (1999) 2.86
Disruption of the type III adenylyl cyclase gene leads to peripheral and behavioral anosmia in transgenic mice. Neuron (2000) 2.73
EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet (1993) 2.72
Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron (1996) 2.47
Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet (1999) 2.35
Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosomes Cancer (1992) 2.31
Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet (1994) 2.28
Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei. Nat Neurosci (1998) 2.20
DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol (1994) 2.18
Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron (1999) 2.17
Survival and acquired genetic alterations in colorectal cancer. Gastroenterology (1992) 2.02
Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet (1999) 1.96
Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc Natl Acad Sci U S A (1995) 1.94
Quality assessment of genetic markers used for therapy stratification. J Clin Oncol (2003) 1.92
Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science (2013) 1.91
Circadian regulation of cAMP response element-mediated gene expression in the suprachiasmatic nuclei. J Biol Chem (1999) 1.85
Calcium-induced exposure of a hydrophobic surface on calmodulin. Biochemistry (1980) 1.85
A new member of the ETS family fused to EWS in Ewing tumors. Oncogene (1997) 1.79
Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest (2001) 1.71
EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol Cell Biol (1998) 1.71
Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome. J Med Genet (2001) 1.70
Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice. J Neurosci (2000) 1.65
Phosphorylation and inhibition of olfactory adenylyl cyclase by CaM kinase II in Neurons: a mechanism for attenuation of olfactory signals. Neuron (1998) 1.63
SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation. EMBO J (2000) 1.62
Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B. J Antibiot (Tokyo) (1977) 1.62
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique. J Clin Oncol (1997) 1.59
Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene (2001) 1.53
INI1 mutations in meningiomas at a potential hotspot in exon 9. Br J Cancer (2001) 1.52
Complex formation between bacitracin peptides and isoprenyl pyrophosphates. The specificity of lipid-peptide interactions. J Biol Chem (1973) 1.51
Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nat Med (2001) 1.46
Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am J Pathol (2000) 1.46
Resolution of adenylate cyclase sensitive and insensitive to Ca2+ and calcium-dependent regulatory protein (CDR) by CDR-sepharose affinity chromatography. Proc Natl Acad Sci U S A (1979) 1.46
Capacitative Ca2+ entry is involved in cAMP synthesis in mouse parotid acini. Am J Physiol (1998) 1.45
Inhibition of Escherichia coli growth and respiration by polymyxin B covalently attached to agarose beads. Biochemistry (1977) 1.45
Type I adenylyl cyclase mutant mice have impaired mossy fiber long-term potentiation. J Neurosci (1998) 1.43
Characterization of the calmodulin binding domain of neuromodulin. Functional significance of serine 41 and phenylalanine 42. J Biol Chem (1991) 1.41
EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth Differ (1996) 1.40
Regulation of calmodulin binding to P-57. A neurospecific calmodulin binding protein. J Biol Chem (1987) 1.40
Identification and characterization of the calmodulin-binding domain of neuromodulin, a neurospecific calmodulin-binding protein. J Biol Chem (1988) 1.39
Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol. J Neurosci (1998) 1.39
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification. Br J Cancer (2007) 1.39
RFLP identified by the anonymous DNA segment OL VII E10 at 18q21.3 (HGM no. D18S8). Nucleic Acids Res (1987) 1.38
CRE-mediated gene transcription in neocortical neuronal plasticity during the developmental critical period. Neuron (1999) 1.34
Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade. Br J Cancer (2008) 1.33
Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol (1996) 1.32
Calcium binding to complexes of calmodulin and calmodulin binding proteins. Biochemistry (1985) 1.27
Cross-linking of iodine-125-labeled, calcium-dependent regulatory protein to the Ca2+-sensitive phosphodiesterase purified from bovine heart. Biochemistry (1979) 1.27
Quantitation of energy coupling between Ca2+, calmodulin, skeletal muscle myosin light chain kinase, and kinase substrates. J Biol Chem (1984) 1.26
Loss of adenylyl cyclase I activity disrupts patterning of mouse somatosensory cortex. Nat Genet (1998) 1.25
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there? Med Pediatr Oncol (2001) 1.23
Ca2+ inhibition of type III adenylyl cyclase in vivo. J Biol Chem (1995) 1.23
Distribution of mRNA for the calmodulin-sensitive adenylate cyclase in rat brain: expression in areas associated with learning and memory. Neuron (1991) 1.21
Analysis of the palmitoylation and membrane targeting domain of neuromodulin (GAP-43) by site-specific mutagenesis. Biochemistry (1993) 1.21
Secretion of the Bordetella pertussis adenylate cyclase from Escherichia coli containing the hemolysin operon. Biochemistry (1990) 1.21
Cloning of a balanced translocation breakpoint in the DiGeorge syndrome critical region and isolation of a novel potential adhesion receptor gene in its vicinity. Hum Mol Genet (1995) 1.20
hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol (2007) 1.20
The CRE/CREB pathway is transiently expressed in thalamic circuit development and contributes to refinement of retinogeniculate axons. Neuron (2001) 1.19
The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet (1994) 1.19
Molecular pathogenesis of peripheral neuroblastic tumors. Oncogene (2010) 1.19
Determination of the free-energy coupling for binding of calcium ions and troponin I to calmodulin. Biochemistry (1982) 1.19
Type I calmodulin-sensitive adenylyl cyclase is neural specific. J Neurochem (1993) 1.18
Calcium-independent stimulation of Bordetella pertussis adenylate cyclase by calmodulin. Biochemistry (1982) 1.18
Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. Genomics (1993) 1.18
Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer (1994) 1.18
Synergistic activation of the type I adenylyl cyclase by Ca2+ and Gs-coupled receptors in vivo. J Biol Chem (1994) 1.17
Identification of the protein kinase C phosphorylation site in neuromodulin. Biochemistry (1990) 1.17
MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer (2010) 1.16
Mechanism of bacitracin action: a specific lipid-peptide interaction. Ann N Y Acad Sci (1974) 1.16
Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence. Proc Natl Acad Sci U S A (1992) 1.15
Stimulation of the type III olfactory adenylyl cyclase by calcium and calmodulin. Biochemistry (1992) 1.14
Calmodulin inhibits entry of Bordetella pertussis adenylate cyclase into animal cells. Biochemistry (1985) 1.14
IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Oncogene (2000) 1.14
Modification of adenylate cyclase activity in LM cells by manipulation of the membrane phospholipid composition in vivo. Proc Natl Acad Sci U S A (1976) 1.12
Regulation of free calmodulin levels by neuromodulin: neuron growth and regeneration. Trends Pharmacol Sci (1990) 1.12
Calmodulin-regulated adenylyl cyclases and neuromodulation. Curr Opin Neurobiol (1997) 1.12
Simultaneous localization of cosmids and chromosome R-banding by fluorescence microscopy: application to regional mapping of human chromosome 11. Proc Natl Acad Sci U S A (1990) 1.12
Intracellular sorting of neuromodulin (GAP-43) mutants modified in the membrane targeting domain. J Neurosci (1994) 1.11
Disruption of Escherichia coli outer membranes by EM 49. A new membrane active peptide. Biochemistry (1976) 1.11
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer (2001) 1.10
Phosphorylation and inhibition of type III adenylyl cyclase by calmodulin-dependent protein kinase II in vivo. J Biol Chem (1996) 1.10
Purification and characterization of a calmodulin-sensitive adenylate cyclase from Bordetella pertussis. Biochemistry (1985) 1.10
The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors. Oncogene (2007) 1.10
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study). Br J Cancer (2011) 1.09
A multiplex real-time pcr assay for the detection of gene fusions observed in solid tumors. Lab Invest (2001) 1.09
Calcium and muscarinic agonist stimulation of type I adenylylcyclase in whole cells. J Biol Chem (1992) 1.09
Enhanced hippocampal CA1 LTP but normal spatial learning in inositol 1,4,5-trisphosphate 3-kinase(A)-deficient mice. Learn Mem (1999) 1.09
Inactivation of the mouse adenylyl cyclase 3 gene disrupts male fertility and spermatozoon function. Mol Endocrinol (2005) 1.09
Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. J Natl Cancer Inst (2000) 1.08
Fluorescence energy transfer analysis of calmodulin-peptide complexes. Biochemistry (1992) 1.08
Loss of alleles on chromosome 18 and on the short arm of chromosome 17 in polyploid colorectal carcinomas. Int J Cancer (1988) 1.08
Intracranial Ewing sarcoma/'peripheral' primitive neuroectodermal tumor of dural origin with molecular genetic confirmation. J Neurooncol (2001) 1.08
Interactions between neurogranin and calmodulin in vivo. J Biol Chem (1999) 1.07
Immunological distinction between calmodulin-sensitive and calmodulin-insensitive adenylate cyclases. J Biol Chem (1987) 1.07